» Articles » PMID: 19584431

Stress-induced Tau Phosphorylation: Functional Neuroplasticity or Neuronal Vulnerability?

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2009 Jul 9
PMID 19584431
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Abnormally phosphorylated tau protein is a key component of the pathology seen in neurodegenerative tauopathies, such as Alzheimer's disease (AD). Despite its association with disease, tau phosphorylation (tau-P) also plays an important role in neuroplasticity, such as dendritic/synaptic remodeling seen in the hippocampus in response to environmental challenges, such as stress. To define the boundaries between neuroplasticity and neuropathology, studies have attempted to characterize the paradigms, stimuli, and signaling intermediates involved in stress-induced tau-P. Supporting an involvement of stress in AD are data demonstrating alterations in stress pathways and peptides in the AD brain and epidemiological data implicating stress exposure as a risk factor for AD. In this review, the question of whether stress-induced tau-P can be used as a model for examining the relationship between functional neuroplasticity and neuronal vulnerability will be discussed.

Citing Articles

Examining the effects of extremely low-frequency magnetic fields on cognitive functions and functional brain markers in aged mice.

Hadzibegovic S, Nicole O, Andelkovic V, de Gannes F, Hurtier A, Lagroye I Sci Rep. 2025; 15(1):8365.

PMID: 40069380 PMC: 11897315. DOI: 10.1038/s41598-025-93230-y.


Hepatic kynurenic acid mediates phosphorylation of Nogo-A in the medial prefrontal cortex to regulate chronic stress-induced anxiety-like behaviors in mice.

Yan L, Wang W, Cheng T, Yang D, Wang Y, Wang Y Acta Pharmacol Sin. 2024; 45(10):2032-2044.

PMID: 38811774 PMC: 11420350. DOI: 10.1038/s41401-024-01302-y.


Modulating heart rate oscillation affects plasma amyloid beta and tau levels in younger and older adults.

Min J, Rouanet J, Martini A, Nashiro K, Yoo H, Porat S Sci Rep. 2023; 13(1):3967.

PMID: 36894565 PMC: 9998394. DOI: 10.1038/s41598-023-30167-0.


Plasma phosphorylated-tau181 levels reflect white matter microstructural changes across Alzheimer's disease progression.

Nabizadeh F, Pourhamzeh M, Khani S, Rezaei A, Ranjbaran F, Deravi N Metab Brain Dis. 2022; 37(3):761-771.

PMID: 35015198 DOI: 10.1007/s11011-022-00908-7.


Reproductive status impact on tau phosphorylation induced by chronic stress.

Munoz-Mayorga D, Rissman R, Morales T Neurobiol Stress. 2020; 13:100241.

PMID: 33344697 PMC: 7739034. DOI: 10.1016/j.ynstr.2020.100241.


References
1.
Sapolsky R . Glucocorticoids, stress, and their adverse neurological effects: relevance to aging. Exp Gerontol. 1999; 34(6):721-32. DOI: 10.1016/s0531-5565(99)00047-9. View

2.
Green K, Billings L, Roozendaal B, McGaugh J, LaFerla F . Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci. 2006; 26(35):9047-56. PMC: 6675335. DOI: 10.1523/JNEUROSCI.2797-06.2006. View

3.
Guillozet-Bongaarts A, Garcia-Sierra F, Reynolds M, Horowitz P, Fu Y, Wang T . Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease. Neurobiol Aging. 2005; 26(7):1015-22. DOI: 10.1016/j.neurobiolaging.2004.09.019. View

4.
Binder L, Frankfurter A, REBHUN L . The distribution of tau in the mammalian central nervous system. J Cell Biol. 1985; 101(4):1371-8. PMC: 2113928. DOI: 10.1083/jcb.101.4.1371. View

5.
Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi H . Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2009; 3(3):186-91. DOI: 10.1016/j.jalz.2007.04.381. View